Join
Live feed
·
INSIDERFilingvia Quantisnow
Pacira BioSciences Inc. logo

Amendment: Director Bigal Marcelo bought $40,834 worth of shares (3,400 units at $12.01), increasing direct ownership by 65% to 8,630 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PCRX· Pacira BioSciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PCRX (Pacira BioSciences Inc.) and more on Quantisnow.